Prevalência e risco transfusional para doenças infectocontagiosas em doadores de sangue
Bortoluzzi, Marcelo Carlos; Dallacosta, Fabiana Meneghetti; Presta, Andréia Antoniuk.
RBM rev. bras. med
; 72(8)ago. 2015.
Artigo em Português | LILACS | ID: lil-772143
Documentos relacionados
Costs and consequences of over-investigation of minor transfusion reactions.
Should adding pain, oxygen saturation and physical assessment to vital signs become the new standard of care for detecting blood transfusion reactions?
Incorporating the entity of under-transfusion into hemovigilance monitoring: Documenting cases due to lack of inventory.
Guideline on the investigation and management of acute transfusion reactions.
Re-scanning the transfusion-transmitted disease horizon.
The monocyte monolayer assay, an <i>in vitro</i> method for prediction of <i>in vivo</i> survival of transfused incompatible red blood cells: a review.
Early recognition of possible transfusion reactions using an electronic automatic notification system for changes in vital signs in patients undergoing blood transfusions.
Unexpected antibody against the high-prevalence P antigen before cardiac surgery.
Clinical consequences of a 30-day interval between antibody identifications.
Bone marrow changes in a fatal case of transfusion associated-Graft versus host disease.